Abstract
The main features of stroke-induced immunosuppression are lymphopenia and deactivation of monocytes in peripheral blood. We hypothesized that lymphocyte-to-monocyte ratio (LMR) in peripheral blood may represent the degree of stroke-induced immunosuppression. To prove this hypothesis, we evaluated whether LMR is associated with risk of post-stroke infection and clinical outcome at 3 months in patients with acute ischemic stroke. We selected patients with stroke in anterior circulation within 24 h from onset. Peripheral blood sampling for differential blood count was performed on days 1 and 7. The LMRs on days 1 and 7 were analyzed to determine associations with excellent outcomes (modified Rankin Scale of score 0–1 at 3 months). One hundred and two patients were included. The initial National Institutes of Health Stroke Scale score (adjusted odd ratio [OR] 0.89; 95% confidence interval [CI], 0.83–0.95; P = 0.001) and LMR on day 7 (adjusted OR 1.49; 95% CI, 1.09–2.02; P = 0.011) were associated with excellent outcomes. LMRs on day 1 were significantly lower in stroke patients with pneumonia (P = 0.007) and pneumonia or urinary tract infection (P = 0.012) than those without infections. LMRs on day 7 were also significantly lower in stroke patients with infection (P = 0.005 in pneumonia, P = 0.003 in urinary tract infection, and P < 0.001 in pneumonia or urinary tract infection) than those without infections. Lower LMRs on day 7 are associated with worse outcomes at 3 months after stroke onset. LMR may be a useful marker for assessing the stroke-induced immunosuppression.
Similar content being viewed by others
References
Vernino S, Brown RD, Sejvar JJ, Sicks JD, Petty GW, O’Fallon WM (2003) Cause-specific mortality after first cerebral infarction: a population-based study. Stroke 34:1828–1832
Marik PE (2001) Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 344:665–671
Dziewas R, Ritter M, Schilling M et al (2004) Pneumonia in acute stroke patients fed by nasogastric tube. J Neurol Neurosurg Psychiatry 75:852–856
Prass K, Meisel C, Höflich C et al (2003) Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198:725–736
Prass K, Braun JS, Dirnagl U, Meisel C, Meisel A (2006) Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 37:2607–2612
Haeusler KG, Schmidt WUH, Föhring F et al (2008) Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis 25:50–58
Vogelgesang A, Grunwald U, Langner S et al (2008) Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 39:237–241
Hoffmann S, Harms H, Ulm L et al (2016) Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia—the PREDICT study. J Cereb Blood Flow Metab. https://doi.org/10.1177/0271678X16671964
Xue J, Huang W, Chen X et al (2017) Neutrophil-to-lymphocyte ratio is a prognostic marker in acute ischemic stroke. J Stroke Cerebrovasc Dis 26:650–657. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.11.010
Tokgoz S, Kayrak M, Akpinar Z, Seyithanoğlu A, Güney F, Yürüten B (2013) Neutrophil lymphocyte ratio as a predictor of stroke. J Stroke Cerebrovasc Dis 22:1169–1174. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.01.011
Tokgoz S, Keskin S, Kayrak M, Seyithanoglu A, Ogmegul A (2014) Is neutrophil/lymphocyte ratio predict to short-term mortality in acute cerebral infarct independently from infarct volume? J Stroke Cerebrovasc Dis 23:2163–2168. https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.04.007
Wang F, Hu S, Ding Y et al (2016) Neutrophil-to-lymphocyte ratio and 30-day mortality in patients with acute intracerebral hemorrhage. J Stroke Cerebrovasc Dis 25:182–187. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.09.013
Langhorne P, Stott DJ, Robertson L et al (2000) Medical complications after stroke: a multicenter study. Stroke 31:1223–1229
Summers D, Leonard A, Wentworth D et al (2009) Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association. Stroke 40:2911–2944
Thompson HJ (2015) Evidence-base for fever interventions following stroke. Stroke 46:e98–e100. https://doi.org/10.1161/STROKEAHA.115.008188
Barber PA, Hill MD, Eliasziw M et al (2005) Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry 76:1528–1533
Chamorro A, Urra X, Planas AM (2007) Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 38:1097–1103
Liesz A, Hu X, Kleinschnitz C, Offner H (2015) Functional role of regulatory lymphocytes in stroke: facts and controversies. Stroke 46:1422–1430. https://doi.org/10.1161/STROKEAHA.114.008608
Dirnagl U, Klehmet J, Braun JS et al (2007) Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 38:770–773
Meisel C, Meisel A (2011) Suppressing immunosuppression after stroke. N Engl J Med 365:2134–2136. https://doi.org/10.1056/NEJMcibr1112454
Harms H, Reimnitz P, Bohner G et al (2011) Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection. Cerebrovasc Dis 32:552–560. https://doi.org/10.1159/000331922
Meisel A, Meisel C, Harms H, Hartmann O, Ulm L (2012) Predicting post-stroke infections and outcome with blood-based immune and stress markers. Cerebrovasc Dis 33:580–588
Liesz A, Dalpke A, Mracsko E et al (2015) DAMP signaling is a key pathway inducing immune modulation after brain injury. J Neurosci 35:583–598. https://doi.org/10.1523/JNEUROSCI.2439-14.2015
Veltkamp R, Gill D (2016) Clinical trials of immunomodulation in ischemic stroke. Neurotherapeutics 13:791–800
Becker KJ (2010) Modulation of the postischemic immune response to improve stroke outcome. Stroke 41:S75–S78
Macrez R, Ali C, Toutirais O et al (2011) Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol 10:471–480. https://doi.org/10.1016/S1474-4422(11)70066-7
Maier IL, Karch A, Mikolajczyk R, Bähr M, Liman J (2015) Effect of beta-blocker therapy on the risk of infections and death after acute stroke—a historical cohort study. PLoS One 10:e0116836. https://doi.org/10.1371/journal.pone.0116836
Starr JB, Tirschwell DL, Becker KJ (2017) Increased infections with β-blocker use in ischemic stroke, a β2-receptor mediated process? Neurol Sci 38:967–974. https://doi.org/10.1007/s10072-017-2877-x
Westendorp WF, Vermeij JD, Brouwer MC et al (2016) Pre-stroke use of beta-blockers does not lower post-stroke infection rate: an exploratory analysis of the preventive antibiotics in stroke study. Cerebrovasc Dis 42:506–511
Pagram H, Bivard A, Lincz LF, Levi C (2017) Immunity and stroke, the hurdles of stroke research translation. Int J Stroke 12:123–131
Acknowledgements
We sincerely thank Chang O Son for proofreading.
Funding
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A3A01019331).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Electronic supplementary material
ESM 1
(DOCX 1817 kb)
Rights and permissions
About this article
Cite this article
Park, MG., Kim, MK., Chae, SH. et al. Lymphocyte-to-monocyte ratio on day 7 is associated with outcomes in acute ischemic stroke. Neurol Sci 39, 243–249 (2018). https://doi.org/10.1007/s10072-017-3163-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-017-3163-7